Medical News

RSS

Month of birth may determine career

Being born in a certain month appears to indicate the statistical likelihood of what job a person will end up with, the study by the UK’s Office for National Statistics has found.

6 Sep 2011

Brown fat may help curb obesity: Study

Australian scientists have pioneered a way to grow in the laboratory “brown fat” - a wondrous tissue that burns energy to generate heat - a breakthrough which they claim could be the latest weapon in the battle against obesity.

6 Sep 2011

Chocolate protects heart but stirs debate on intake

A new study shows that chocolates are beneficial for heart health. The study published in the British Medical Journal and presented at the European Cardiology Society's annual congress in Paris analyzed data from seven studies involving 114,009 adults, ages 25 to 93, and including information on their diets and occurrences of cardiovascular disease over periods from eight to 16 years.

6 Sep 2011

Walnuts may prevent breast cancer

A new study has found that eating a handful of walnuts on a regular basis may reduce women’s risk of developing breast cancer. Researchers from the Marshall University observed in mice that consuming 2 ounces of walnuts each day reduced the growth of breast cancer tumors.

6 Sep 2011

Tick-borne disease in US blood supply

A tick-borne infection known as Babesiosis, which can cause severe disease and even death, is becoming a growing threat to the U.S. blood supply, government researchers said on Monday.

6 Sep 2011

Youth immunization rates encouraging: CDC report

According to a survey by the Centers for Disease Control and Prevention (CDC) out Monday, more and more American adolescents are receiving recommended vaccines.

6 Sep 2011

Sperm donors may father over 150 children

Most sperm donors assume that they would father a few children. But with the news that some donors have fathered over 100 kids there have been calls for tighter regulation. It has been discovered that some sperm banks allow donors to father lots and lots of kids — one has over 150. And with these very large groups of half-siblings come risks: rare genetic conditions could be spread more widely through the gene pool, and children of the same donor could meet and, unbeknownst to them, commit incest.

6 Sep 2011

Mental health problems ail nearly half of all Americans: Report

According to a new government report about half of Americans will experience some form of mental health problem at some point in their life. The report stresses that more must be done to help the population with mental health problems.

6 Sep 2011

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

BioDelivery Sciences International, Inc. announced positive preliminary results from its Phase 1 study assessing the pharmacokinetics of a BEMA Buprenorphine/Naloxone formulation.

6 Sep 2011

Golden Meditech launches Taiwan representative office

Golden Meditech Holdings Limited, which embodies a leading medical devices enterprise, a major brand name in haematology hospital and the largest stem cell cord blood banking operator in China, is pleased to announce the launch of its Taiwan representative office today.

6 Sep 2011

Discovery Labs files Complete Response to FDA for SURFAXIN to treat RDS in premature infants

Discovery Labs, Inc. today announced that, on September 2, 2011, it submitted its Complete Response to the 2009 Complete Response Letter issued by the U.S. Food and Drug Administration (FDA) for SURFAXIN(lucinactant) for the prevention of respiratory distress syndrome (RDS) in premature infants.

6 Sep 2011

Enrollment complete in DURECT's POSIDUR Phase III study for post-surgical pain

DURECT Corporation announced today the dosing of the last patient in the U.S. pivotal Phase III clinical study for POSIDUR known as BESST.

6 Sep 2011

NINDS awards NeuroSigma STTR Phase I grant to support development of eTNS therapy for epilepsy

NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.

6 Sep 2011

Concentric Medical launches Trevo Pro 4 device for acute ischemic stroke

Concentric Medical, Inc. today announced the full European launch of Trevo Pro 4 System. This next standard in Stentriever technology has an enhanced design to further promote clot integration across clot types in patients suffering an acute ischemic stroke.

6 Sep 2011

Vertex VX-509 12-week Phase 2a study on RA meets two primary endpoints

Vertex Pharmaceuticals Incorporated today announced that treatment with the investigational selective oral JAK3 inhibitor VX-509 in a Phase 2a trial resulted in substantial and statistically significant improvements in multiple measurements of rheumatoid arthritis (RA) activity.

6 Sep 2011

First Edition: September 6, 2011

Today's early morning highlights from the major news organizations include reports from a GOP presidential candidate forum in South Carolina and analysis of what to expect as Congress returns to Washington.

6 Sep 2011

NanoViricides selects NV-INF-1 anti-influenza drug for FDA submission

NanoViricides, Inc. announced today that it has selected a clinical candidate, now designated NV-INF-1, for FDA submission in its highly successful FluCide anti-influenza therapeutics program.

6 Sep 2011

Comanche County Memorial Hospital chooses eClinicalWorks' EHR solution

eClinicalWorks, a market leader in ambulatory clinical systems, today announced that Oklahoma's Comanche County Memorial Hospital has chosen the eClinicalWorks comprehensive electronic health records (EHR) solution for its employed physicians across 28 locations that are multi-specialty.

6 Sep 2011

Shiva Biomedical, CorMedix to extend CRMD001 phase III trial in chronic kidney disease

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced it has amended its agreement with Shiva Biomedical, LLC.

6 Sep 2011

ERS urges EU to take action on chronic respiratory diseases

Respiratory diseases are one of the leading causes of death and suffering in the EU. The challenge Europe is facing in this field goes far beyond public health: lung diseases currently cause an annual cost of €100 billion and threaten the Europe 2020 strategy and the goal to have 75% of the working population employed and productive.

6 Sep 2011